Wells Fargo
FLNA

Wells Fargo’s Filana Therapeutics FLNA Stock Holding History

Wells Fargo’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,000
Closed -$418K – 7691
2022
Q3 		$418K Buy
+10,000
New +$270K ﹤0.01% 3810

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Wells Fargo's FLNA Position: Q1 2026 in Review

Wells Fargo reduced its Filana Therapeutics (FLNA) stake by 48% in Q1 2026, selling an estimated $16.2K and leaving 8,421 shares worth $14.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5876.

Wells Fargo first reported a position in FLNA in Q1 2014 and has held it in 49 quarters since. The position peaked at $1.76M in Q4 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Wells Fargo held 8,421 shares of Filana Therapeutics worth $14.2K as of Q1 2026.
  • Wells Fargo sold 7,883 Filana Therapeutics shares in Q1 2026, an estimated $16.2K.
  • Filana Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5876 holding.
  • Wells Fargo first reported a position in Filana Therapeutics in Q1 2014 and has held it in 49 quarters since.
  • Wells Fargo's Filana Therapeutics position peaked at $1.76M in Q4 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.